A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : CTL / cytotoxic T cells

[Related PubMed/MEDLINE]
Total Number of Papers: 903
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   CTL  (>> Co-occurring Abbreviation)
Long Form:   cytotoxic T cells
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Co-circulation of dengue virus serotypes in Central India: Evidence of prolonged viremia in DENV-2. DENV
2019 Effects of T cell subsets with different proportions on renal function and blood lipids in patients with preeclampsia. GFR, PE, TC, TG, UA
2019 Fcgamma Receptor Type I (CD64)-Mediated Impairment of the Capacity of Dendritic Cells to Activate Specific CD8 T Cells by IgG-opsonized Friend Virus. Ags, DCs, FcgammaRs, FV, ICs
2019 Insights into the dynamics of memory, effector and apoptotic cytotoxic T lymphocytes in channel catfish, Ictalurus punctatus. ---
2019 Maintenance of long remission in adult T-cell leukemia by Tax-targeted vaccine: A hope for disease-preventive therapy. allo-HSCT, ATL, GVH, HTLV-1
2019 Persistence of Integrase-Deficient Lentiviral Vectors Correlates with the Induction of STING-Independent CD8+ T Cell Responses. DCs, IDLVs, IRF, RIG-I, STING
2019 Pregnancy-Associated Alterations of Peripheral Blood Immune Cell Numbers in Domestic Sows Are Modified by Social Rank. HR, NK
2019 Radiotherapy and Cisplatin Increase Immunotherapy Efficacy by Enabling Local and Systemic Intratumoral T-cell Activity. TME
2019 Subclonal STAT3 mutations solidify clonal dominance. CDR3, NGS, T-LGLL, TCR
10  2018 APOBEC3G Regulation of the Evolutionary Race Between Adaptive Immunity and Viral Immune Escape Is Deeply Imprinted in the HIV Genome. A3G
11  2018 Cytotoxic T lymphocytes from cattle sharing the same MHC class I haplotype and immunized with live Theileria parva sporozoites differ in antigenic specificity. ECF
12  2018 Enhancement of therapeutic DNA vaccine potency by melatonin through inhibiting VEGF expression and induction of antitumor immunity mediated by CD8+ T cells. HPV, LDH, MLT, VEGF
13  2018 Epstein-Barr virus post-transplant lymphoproliferative disease (PTLD) after hematopoietic stem cell transplantation. EBV, HSCT, PTLD
14  2018 GoldiRunx and Remembering Cytotoxic Memory. ---
15  2018 HSP70L1-mediated intracellular priming of dendritic cell vaccination induces more potent CTL response against cancer. CEA, DCs, HSP, HSP70L1
16  2018 Icaritin Improves Antibody-Induced Thrombocytopenia in a Mouse Model by Regulating T-cell Polarization. CBA, ELISA, ICT, ITP, TGF-beta, Th
17  2018 IFN-gamma-mediated inhibition of lung cancer correlates with PD-L1 expression and is regulated by PI3K-AKT signaling. ---
18  2018 Live attenuated influenza vaccine viral vector induces functional cytotoxic T-cell immune response against foreign CD8+ T-cell epitopes inserted into NA and NS1 genes using the 2A self-cleavage site. LAIV, RSV
19  2018 PD-1 blockade potentially enhances adoptive cytotoxic T cell potency in a human acute myeloid leukaemia animal model. AML, PB, PBMCs, PD-1
20  2018 Phenotype of p53 wild-type epitope-specific T cells in the circulation of patients with head and neck cancer. HNSCC, tet, WT
21  2018 Role of Integrin Signaling Activation on the Development of Human T Cell Leukemia Virus-1 (HTLV-1)-Associated Myelopathy/Tropical Spastic Paraparesis: Its Relationship to HTLV-1-Infected CD4+ T Cell Transmigrating Activity into the Tissues. HTLV-1
22  2018 The 180 splice variant of NCAM-containing exon 18-is specifically expressed in small cell lung cancer cells. NCAM, NSCLC, PBMC, SCLC
23  2018 The Antigen ASB4 on Cancer Stem Cells Serves as a Target for CTL Immunotherapy of Colorectal Cancer. CSC
24  2018 [In Vivo Antigen Delivery to Dendritic Cells-A Novel Peptide Vaccine for Cancer Therapy]. OVA, XCL1
25  2017 Biomimetic Magnetosomes as Versatile Artificial Antigen-Presenting Cells to Potentiate T-Cell-Based Anticancer Therapy. aAPCs
26  2017 Blocking IL-10 signalling at the time of immunization does not increase unwanted side effects in mice. IL-10, NOD
27  2017 Card9 controls Dectin-1-induced T-cell cytotoxicity and tumor growth in mice. ---
28  2017 CD4+ T Cell Help Confers a Cytotoxic T Cell Effector Program Including Coinhibitory Receptor Downregulation and Increased Tissue Invasiveness. ---
29  2017 Changes in peripheral blood T-cell balance after percutaneous tumor ablation. Th2
30  2017 Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation. GBM, HEVs, LTbetaR, VEGF
31  2017 Combined immunotherapy: CTLA-4 blockade potentiates anti-tumor response induced by transcutaneous immunization. ---
32  2017 Cytokines and metabolic factors regulate tumoricidal T-cell function during cancer immunotherapy. ---
33  2017 Design of therapeutic vaccines as a novel antibody therapy for cardiovascular diseases. Ang II
34  2017 Effects of early pregnancy on uterine lymphocytes and endometrial expression of immune-regulatory molecules in dairy heifers. CTLA-4, LAG3, NK
35  2017 Epidrugs in the Immunotherapy of Cutaneous and Uveal Melanoma. ACT, APM, DNMTs, EZH2, HDACs, HLA, miRNA, NK, TAAs
36  2017 Hepatitis C Virus-Specific T Cell Receptor mRNA-Engineered Human T Cells: Impact of Antigen Specificity on Functional Properties. HCV, NS, PBLs, TCRs
37  2017 HIV-I Nef inhibitors: a novel class of HIV-specific immune adjuvants in support of a cure. cART, MHC-I
38  2017 Human galectin-9 on the porcine cells affects the cytotoxic activity of M1-differentiated THP-1 cells through inducing a shift in M2-differentiated THP-1 cells. hGal-9, NK, rhGal-9
39  2017 Identification of B and T cell epitope based peptide vaccine from IGF-1 receptor in breast cancer. IGF-1R, MHC, Th
40  2017 IFN-gamma is required for cytotoxic T cell-dependent cancer genome immunoediting. CNAs, ERK
41  2017 Inhibition of allogeneic cytotoxic T cell (CD8+) proliferation via polymer-induced Treg (CD4+) cells. MLR, SVA-mPEG, Treg
42  2017 M(IL-4) Tissue Macrophages Support Efficient Interferon-Gamma Production in Antigen-Specific CD8+ T Cells with Reduced Proliferative Capacity. MHC, Sp
43  2017 Novel Identified HLA-A*0201-Restricted Hantaan Virus Glycoprotein Cytotoxic T-Cell Epitopes Could Effectively Induce Protective Responses in HLA-A2.1/Kb Transgenic Mice May Associate with the Severity of Hemorrhagic Fever with Renal Syndrome. GP, HFRS, HTNV
44  2017 Peptide splicing by the proteasome. MHC
45  2017 Programmed Cell Death 1 (PD-1) and Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA-4) in Viral Hepatitis. CTLA-4, HBV, HCV, MHC, PD-1
46  2017 Sp17 Protein Expression and Major Histocompatibility Class I and II Epitope Presentation in Diffuse Large B Cell Lymphoma Patients. CTAs, DLBCL, Sp17, Th
47  2017 T cells presenting viral antigens or autoantigens induce cytotoxic T cell anergy. PCD
48  2017 Tracking the Fate and Origin of Clinically Relevant Adoptively Transferred CD8+ T Cells In Vivo. CR, HTTCS, VLF
49  2017 Triggering of TLR-3, -4, NOD2, and DC-SIGN reduces viral replication and increases T-cell activation capacity of HIV-infected human dendritic cells. DCs, HS
50  2016 A20 Deficiency in Lung Epithelial Cells Protects against Influenza A Virus Infection. ---
51  2016 Alcohol exposure differentially effects anti-tumor immunity in females by altering dendritic cell function. DCs
52  2016 An effective cytokine adjuvant vaccine induces autologous T-cell response against colon cancer in an animal model. LDH
53  2016 Antigen-specific T cell Redirectors: a nanoparticle based approach for redirecting T cells. ATR
54  2016 Atorvastatin (Lipitor) attenuates the effects of aspirin on pancreatic cancerogenesis and the chemotherapeutic efficacy of gemcitabine on pancreatic cancer by promoting M2 polarized tumor associated macrophages. DMBA, MDSC, Th
55  2016 Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is involved in cervical cancer stemness and can be a target of immunotherapy. BORIS, CICs, CSCs, CT, HLA, SFs
56  2016 C-C chemokine receptor type-4 transduction of T cells enhances interaction with dendritic cells, tumor infiltration and therapeutic efficacy of adoptive T cell transfer. ACT, CCL22, CCR4, DC
57  2016 Chronic Myelocytic Leukemia (CML) Patient-Derived Dendritic Cells Transfected with Autologous Total RNA Induces CML-Specific Cytotoxicity. CML, CML, DCs
58  2016 Classical and non-classical HLA class I aberrations in primary cervical squamous- and adenocarcinomas and paired lymph node metastases. AC, DFS, DSS, HLA, LN, NK, SCC
59  2016 CRTAM determines the CD4+ cytotoxic T lymphocyte lineage. CRTAM
60  2016 Glycosylation Status of CD43 Protein Is Associated with Resistance of Leukemia Cells to CTL-Mediated Cytolysis. mAbs
61  2016 Human Cytotoxic T Lymphocytes Form Dysfunctional Immune Synapses with B Cells Characterized by Non-Polarized Lytic Granule Release. Arl8, CLL, CTLs, LAT
62  2016 IL-12 and IL-4 activate a CD39-dependent intrinsic peripheral tolerance mechanism in CD8(+) T cells. Treg
63  2016 Immune responses to WT1 in patients with AML or MDS after chemotherapy and allogeneic stem cell transplantation. AML/MDS, CCR, ELISPOT, SCT, WT1
64  2016 Impaired functional responses in follicular lymphoma CD8+TIM-3+ T lymphocytes following TCR engagement. FL, Tim-3
65  2016 In silico designing breast cancer peptide vaccine for binding to MHC class I and II: A molecular docking study. MHC, Th
66  2016 In vivo enhancement of the MAGE-specific cellular immune response by a recombinant MAGE1-MAGE3-TBHSP70 tumor vaccine. MAGEs
67  2016 Induction of antigen-specific cytotoxic T-cell response by dendritic cells generated from ecto-mesenchymal stem cells infected with an adenovirus containing the MAGE-D4a gene. DCs, EMSC, IFN-gamma, MAGE-D4a, MTT
68  2016 Innate and adaptive immunity to human beta cell lines: implications for beta cell therapy. NK
69  2016 Multi-layered Gag-specific immunodominant responses contribute to improved viral control in the CRF01_AE subtype of HIV-1-infected MSM subjects. ELISPOT, HIV-1, MSM
70  2016 Notwithstanding Circumstantial Alibis, Cytotoxic T Cells Can Be Major Killers of HIV-1-Infected Cells. HIV-1, SIV
71  2016 Opposing Development of Cytotoxic and Follicular Helper CD4T Cells Controlled by the TCF-1-Bcl6 Nexus. GzmB, Th
72  2016 Phosphoproteomic Analyses of Interleukin 2 Signaling Reveal Integrated JAK Kinase-Dependent and -Independent Networks in CD8(+) T Cells. IL-2, JAKs
73  2016 Prognostic significance of CD169-positive lymph node sinus macrophages in patients with endometrial carcinoma. EC, LN, RLN
74  2016 Short Peptide Vaccine Induces CD4+ T Helper Cells in Patients with Different Solid Cancers. sp
75  2016 The IDO1 selective inhibitor epacadostat enhances dendritic cell immunogenicity and lytic ability of tumor antigen-specific T cells. DCs, IDO1, LPS, PBMCs
76  2016 The light and the dark sides of Interleukin-10 in immune-mediated diseases and cancer. IL-10
77  2016 Vaccines Combined with Immune Checkpoint Antibodies Promote Cytotoxic T-cell Activity and Tumor Eradication. PLG
78  2015 A Novel Bispecific Antibody against Human CD3 and Ephrin Receptor A10 for Breast Cancer Therapy. BsAb, E/T, EphA10
79  2015 Accumulation Mechanisms of CD4(+)CD25(+)FOXP3(+) Regulatory T Cells in EBV-associated Gastric Carcinoma. EBV, EBVaGCs, EBVnGC, PBMCs
80  2015 Analgesia in mice with experimental meningitis reduces pain without altering immune parameters. CNS, LCMV
81  2015 Autologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma. DAMPs, WT
82  2015 Carbopol improves the early cellular immune responses induced by the modified-life vaccine Ingelvac PRRS MLV. Th
83  2015 CD107a as a marker of activation in chicken cytotoxic T cells. IBV, PMA
84  2015 CEA/CD3-bispecific T cell-engaging (BiTE) antibody-mediated T lymphocyte cytotoxicity maximized by inhibition of both PD1 and PD-L1. BiTE, CEA
85  2015 Comprehensive Analysis of the Naturally Processed Peptide Repertoire: Differences between HLA-A and B in the Immunopeptidome. B-LCL
86  2015 Cross-Reactivity Between Influenza Matrix- and HIV-1 P17-Specific CTL-A Large Cohort Study. ART
87  2015 Establishing the pig as a large animal model for vaccine development against human cancer. SLAs
88  2015 Graft versus leukemia response without graft-versus-host disease elicited by adoptively transferred multivirus-specific T-cells. CMV, EBV, FISH, PHA
89  2015 Hepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus control. HCV, SVR
90  2015 HLA Preferences for Conserved Epitopes: A Potential Mechanism for Hepatitis C Clearance. HCV, HLA
91  2015 HLA-B polymorphisms and intracellular assembly modes. ER, HLA, NK
92  2015 HPV-E7 delivered by engineered exosomes elicits a protective CD8⁺ T cell-mediated immune response. HPV, VLPs
93  2015 K562-Derived Whole-Cell Vaccine Enhances Antitumor Responses of CAR-Redirected Virus-Specific Cytotoxic T Lymphocytes In Vivo. APCs, CAR, CMV, CMV-CTLs, EBV, iC9
94  2015 Long-term Outcome of Extranodal NK/T Cell Lymphoma Patients Treated With Postremission Therapy Using EBV LMP1 and LMP2a-specific CTLs. CR, EBV, ENKTCL, HDT/SCT, LMP, OS, PFS
95  2015 Measles Virus Epitope Presentation by HLA: Novel Insights into Epitope Selection, Dominance, and Microvariation. HLA, MV
96  2015 Patient-adapted, specific activation of HIV-1 by customized TAL effectors (TALEs), a proof of principle study. ART, LRAs, TALE, TALEs
97  2015 Prior population immunity reduces the expected impact of CTL-inducing vaccines for pandemic influenza control. IAV
98  2015 Splenectomy inhibits non-small cell lung cancer growth by modulating anti-tumor adaptive and innate immune response. MDSC, NSCLC
99  2015 [Effect of Tanreqing injection on immune activity of peripheral blood lymphocytes of patients with lung cancer]. FCM, NK, PHA
100  2015 [Tanreqing injection promotes the immune function of mice with Lewis lung carcinoma after chemotherapy]. IFN-gamma, TI, TNF-alpha